Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Finger

Showing results (231-240 of 262) with videos related to

Pageof 27
Sort By:
Ophthalmology|February 13, 2008
Baseline echographic characteristics of tumors in eyes of patients enrolled in the Collaborative Ocular Melanoma Study: COMS report no. 29, H Culver Boldt, Sandra Frazier Byrne, et al.
Physical Review Letters|December 9, 2017
Control of Chiral Magnetism Through Electric Fields in Multiferroic Compounds above the Long-Range Multiferroic TransitionJ Stein, M Baum, S Holbein, et al.
Melanoma Research|February 21, 2012
Expression of neurotrophin receptors by retinoinvasive uveal melanomaTatyana Milman, Dan-Ning Hu, Steven A McCormick, et al.
Brachytherapy|March 22, 2023
First clinical implementation of Yttrium-90 Disc Brachytherapy after FDA clearancePaul T Finger, Robert Stewart, Mark J Rivard, et al.
Medical Physics|March 3, 2011
Comparison of dose calculation methods for brachytherapy of intraocular tumorsMark J Rivard, Sou-Tung Chiu-Tsao, Paul T Finger, et al.
JAMA Ophthalmology|April 26, 2014
Ocular adnexal follicular lymphoma: a multicenter international studyPeter K Rasmussen, Sarah E Coupland, Paul T Finger, et al.
Medical Physics|October 9, 2012
Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABSSou-Tung Chiu-Tsao, Melvin A Astrahan, Paul T Finger, et al.
Ophthalmology|March 24, 2020
The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma: IV. Local Treatment Failure and Enucleation in the First 5 Years after Brachytherapy. COMS Report No. 19Lee M Jampol, Claudia S Moy, Timothy G Murray, et al.
Ophthalmology|December 6, 2002
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19Lee M Jampol, Claudia S Moy, Timothy G Murray, et al.
JAMA Ophthalmology|November 10, 2017
Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter CohortMarina K H Knudsen, Peter K Rasmussen, Sarah E Coupland, et al.
Pageof 27

Showing results (231-240 of 262) with videos related to

Sort By:
Pageof 27
Ophthalmology|February 13, 2008
Baseline echographic characteristics of tumors in eyes of patients enrolled in the Collaborative Ocular Melanoma Study: COMS report no. 29, H Culver Boldt, Sandra Frazier Byrne, et al.
Physical Review Letters|December 9, 2017
Control of Chiral Magnetism Through Electric Fields in Multiferroic Compounds above the Long-Range Multiferroic TransitionJ Stein, M Baum, S Holbein, et al.
Melanoma Research|February 21, 2012
Expression of neurotrophin receptors by retinoinvasive uveal melanomaTatyana Milman, Dan-Ning Hu, Steven A McCormick, et al.
Brachytherapy|March 22, 2023
First clinical implementation of Yttrium-90 Disc Brachytherapy after FDA clearancePaul T Finger, Robert Stewart, Mark J Rivard, et al.
Medical Physics|March 3, 2011
Comparison of dose calculation methods for brachytherapy of intraocular tumorsMark J Rivard, Sou-Tung Chiu-Tsao, Paul T Finger, et al.
JAMA Ophthalmology|April 26, 2014
Ocular adnexal follicular lymphoma: a multicenter international studyPeter K Rasmussen, Sarah E Coupland, Paul T Finger, et al.
Medical Physics|October 9, 2012
Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABSSou-Tung Chiu-Tsao, Melvin A Astrahan, Paul T Finger, et al.
Ophthalmology|March 24, 2020
The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma: IV. Local Treatment Failure and Enucleation in the First 5 Years after Brachytherapy. COMS Report No. 19Lee M Jampol, Claudia S Moy, Timothy G Murray, et al.
Ophthalmology|December 6, 2002
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19Lee M Jampol, Claudia S Moy, Timothy G Murray, et al.
JAMA Ophthalmology|November 10, 2017
Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter CohortMarina K H Knudsen, Peter K Rasmussen, Sarah E Coupland, et al.
Pageof 27